SCHEMBL30311147

SCHEMBL30311147

CC(C)(C)OC(=O)N1CCCC[C@H]1c1cc2nc(N3CC(O[Si](c4ccccc4)(c4ccccc4)C(C)(C)C)C3)cc(CO)n2n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.33
▸ TSHR P16473 3/20 0.33
▸ LMNA P02545 3/20 0.33
▸ ABCB1 P08183 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33
▸ USP30 Q70CQ3 2/20 0.33
▸ NR1H2 P55055 2/20 0.32
▸ NR1H3 Q13133 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PRMT5 O14744 1/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KDM1A O60341 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30311372 0.91 DPP4 (0.33) DPP4ALDH1A1TSHRLMNAABCB1
SCHEMBL22175842 0.84 GPR119 (0.36) ALDH1A1TSHRL3MBTL1MEN1KMT2A
SCHEMBL30311324 0.84 GPR119 (0.36) ALDH1A1TSHRL3MBTL1MEN1KMT2A
SCHEMBL30311180 0.78 KLK7 (0.41) DPP4ALDH1A1TSHRLMNAABCB1
SCHEMBL30311334 0.77 KLK7 (0.40) DPP4ALDH1A1TSHRLMNAABCB1
SCHEMBL2738201 0.75 ALDH1A1 (0.35) ALDH1A1TSHRLMNAL3MBTL1MEN1
SCHEMBL30311421 0.74 KLK7 (0.37) DPP4ABCB1USP30PRMT5NPSR1
SCHEMBL30311192 0.73 NR1H2 (0.33) ALDH1A1USP30NR1H2NR1H3
SCHEMBL22164343 0.73 KDM4E (0.33) ALDH1A1LMNAL3MBTL1KDM4EHPGD
SCHEMBL2737925 0.72 GPR119 (0.38) ALDH1A1TSHRL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230069963-A1 PYRAZOLO[1,5-A]PYRIMIDINE MACROCYCLIC COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2023-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069963-A1 PYRAZOLO[1,5-A]PYRIMIDINE MACROCYCLIC COMPOUND ZC3HAV1, ZC3HAV1L, IL5 DPP4 57/4885ALDH1A1 2801/4885TSHR 3277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback